Items where Author is "Mirfeizi, Z."
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 2.
(2022) Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia (R)) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial. ARTHRITIS RESEARCH & THERAPY. ISSN 1478-6354 1478-6362 J9 - ARTHRITIS RES THER
(2021) Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis (ASQA): A Multicenter Post-marketing Surveillance Study. Advances in Therapy. pp. 1290-1300. ISSN 0741-238X